Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Value ETF GVUS Tracking for Major Milestone This Fall

BY | ETF Database
9:30 am ET 07/22/26 | 6 VIEWS
Value investing and investor portfolios can sometimes feel like an endless “will they, won’t they?” story. Investors often wait for the right sign or moment to add value exposure, but frequently balk for fear of losing out on growthier upside. Thanks to ETFs, however, investors can get flexible, low-cost options in the value ETF space that outperform — like the MarketBeta Russell 100 Value Equity ETF (GVUS B-).Key Takeaways: Value ETF GVUS has returned 28.4% over the last 12 months. That has outperformed its ETF Database Category average in that time, which sat at 24.5%.  Its three-year ETF milestone looms this fall, too, which may see interest in it spike. GVUS launched in November 2023, and is poised to hit its important three-year ETF milestone this fall. The milestone frequently brings new attention to ETFs, with funds able to tout three years of performance data. That also gets them in front of many more investors, with ETFs hitting three years added to many brokerage listings.Value ETF GVUS: Performance for a Lower FeeThat could help the value ETF GVUS spike and build on an already strong year. The strategy charges 12 basis points (bps), a relatively small ask for its performance. GVUS has returned 18.4% YTD, according to ETF Database data. It has returned 28.4% over the last 12 months, too. That has helped the value ETF outperform the ETF Database Large Cap Value Equities category average in both time frames. The average return as of July 22 sat at 15.1% and 24.5%, YTD and over one year, respectively.  See more: Now’s the Time for Emerging Markets Stocks GVUS has done this by tracking the Russell 1000 Value 40 Act Daily Capped Index. The index provides exposure to large- and mid-cap U.S. stocks from the Russell 1000 index. It screens for stocks from that index with lower forecasted growth and lower price-to-book ratios. The fund also caps single issuer weights at 22.5%, and all issuer weights above 4.5% at 22.5%, overall. The fund does invest in some big names that the broad market holds, like Apple, Inc. (AAPL), capped. However, it offers exposure to names one would expect to find outside of growth funds, as well. GVUS also holds big healthcare and financials names. Together, it represents a solid, low-cost value ETF offering for investors to consider. For more news, information, and strategy, visit the Future ETFs Content Hub.

More Commentary

Offense & Defense: The Infrastructure ETF Playbook
BY | ETF Database
9:00 am ET 07/22/26 | 7 VIEWS
Hotchkis & Wiley Debuts New ETF Share Classes for 2 Existing Strategies
BY | ETF Database
12:51 pm ET 07/22/26 | 4 VIEWS
Concentration Risk Continues: Why Nows the Time to Diversify
BY | ETF Database
9:00 am ET 07/22/26 | 7 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.